The largest database of trusted experimental protocols

Taqman array human microrna card set v3

Manufactured by Thermo Fisher Scientific
Sourced in United States

The TaqMan Array Human MicroRNA Card Set v3.0 is a pre-configured array of TaqMan MicroRNA Assays designed for the quantitative analysis of human microRNA expression. The card set includes assays for 754 human microRNAs. It is intended for use with real-time PCR instrumentation.

Automatically generated - may contain errors

9 protocols using taqman array human microrna card set v3

1

Profiling Human microRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA (including small RNA) was extracted from 50 mg tissue samples with Direct-zol RNA Miniprep Plus kit (Zymo Research, Irvine, CA, USA); subsequently, RNA concentration was measured using a NanoDrop ultraviolet (UV) spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Reverse transcription was performed using TaqMan® MicroRNA Reverse Transcription Kit with Megaplex™ RT Primers, Human Pool Set v3.0 (Thermo Fisher Scientific, USA) and 500 ng of total RNA in a reaction volume of 7.5 µL, separately for each of two pools of miRNA. Finally, quantitative PCR was performed in a ViiA7 Real-Time PCR System using TaqMan Array Human MicroRNA Card Set v3.0 (Thermo Fisher Scientific, USA). This set enables quantitation of 472 previously described human microRNAs and three housekeeping genes as endogenous controls (stably expressed small noncoding RNAs: U6 snRNA, RNU44, and RNU48) to aid in data normalization. The same threshold value was manually set for all targets, and only miRNA assays with Ct values ≤ 32 were further analyzed. The relative quantity (RQ) of each target was calculated using the ΔCt method, in relation to mean expression of three endogenous controls.
+ Open protocol
+ Expand
2

Extracellular Vesicle miRNA Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
miRNA expression analysis was performed by qRT-PCR array on three different samples of BMSC-EVs. Briefly, RNA was extracted from purified EVs by mirVana Isolation Kit (Thermo Fisher Scientific, Waltham, MA, USA), according with manufacturer’s instruction. RNA concentration was measured by Nanodrop ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA), and the ratio 260/280 and 260/230 showed absence of contaminants. Fifty nanograms of total RNA were retro-transcribed to cDNA with TaqMan® MicroRNA Reverse Transcription Kit (Thermo Fisher Scientific, Waltham, MA, USA). cDNA was pre-amplified with Megaplex™ RT Primers, Human Pool Set v3.0 and TaqMan® PreAmp Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) by using Veriti Thermal Cycler (Thermo Fisher Scientific, Waltham, MA, USA). The expression profile of a panel of 754 human miRNAs was evaluated by TaqMan® Array Human MicroRNA Card Set v3.0 (Thermo Fisher Scientific, Waltham, MA, USA) with QuantStudio12k Flex system (Thermo Fisher Scientific, Waltham, MA, USA). ExpressionSuite Software 1.1 (Thermo Fisher Scientific, Waltham, MA, USA) was used to calculate Ct values. Values of Amp score < 1.1 or Cq conf < 0.7 or Ct > 34 were excluded from analysis. Only miRNAs expressed in all samples of the same group were included for analysis.
+ Open protocol
+ Expand
3

Profiling miRNA Expression in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
We determined miRNA expression profile alteration in cell culture by TaqMan Array Human MicroRNA Card Set v3.0 (Thermofisher Scientific, Cat#: 4444913) containing assays for a total 754 of human microRNAs as described before [28 (link)]. Individual miRNA expression was determined on the Viia 7 Real-Time PCR System (Life Technologies) [27 (link)] using the individual TaqMan assays for miR-1 (Assay ID: 000385).
+ Open protocol
+ Expand
4

Profiling Differentially Expressed miRNAs in OSCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
To select differentially expressed miRNAs, qRT-PCR array analysis was performed on EVs isolated from five patients with OSCC and five healthy controls. The concentration of selected RNA samples was up to 20 ng/μl and 50 ng of total RNA were retro-transcribed to cDNA with TaqMan® MicroRNA Reverse Transcription Kit (Thermo Fisher Scientific). cDNA was pre-amplified with Megaplex™ RT Primers, Human Pool Set v3.0 and TaqMan® PreAmp Master Mix (Thermo Fisher Scientific) using a Veriti Thermal Cycler (Thermo Fisher Scientific). The expression profile of a panel of 754 human microRNAs was evaluated by a TaqMan® Array Human MicroRNA Card Set v3.0 (Thermo Fisher Scientific) using the real-time thermal cycler 7900HT (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

Quantitative Analysis of miRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TaqMan array human microRNA card set v3.0 (Applied Biosystems, Calsbad, CA, USA)was performed to compare miRNA expression levels between tumor tissues and control. The set provided an accurate quantitative value of 754 human microRNAs and aligned with the Sanger miRBase v20. cDNA samples were obtained from different groups, which were loaded on cards and run on real-time system. Data was exported and analyzed in the SDS v2.0 software. (Applied Biosystems, USA) as previous description10 (link). Briefly, the lower signal genes (<300 pixels) were excluded from the results. Statistical difference was compared by using the two sided t-test with unequal variance assumptions. The false discovery rate was performed to correct for multiple hypothesis testing. At least three independent samples were selected to calculate the average density of hybridization signals. Differentially expressed genes were selected using both a false discovery rate of less than 0.01 and a fold-change greater than 2.0 or less than 2.0.
+ Open protocol
+ Expand
6

Circulating miRNA Profiling in Non-Muscle Invasive Bladder Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Global miRNA profiling was performed on serum samples from ten NMIBC patients and ten sex- and age-matched healthy subjects using TaqMan® Array Human MicroRNA Card Set v3.0 (Applied Biosystems, Foster City, CA, USA), which contains probes for 754 human miRNAs. Briefly, total circulating RNA was reverse-transcribed using TaqMan® MicroRNA Reverse Transcription Kit and the Megaplex™ RT Primers followed by a pre-amplification reaction using TaqMan® PreAmp Master Mix and Megaplex PreAmp Primers. Preamplified target cDNAs were then mixed with TaqMan® Universal PCR Master Mix and loaded onto the TaqMan® MicroRNA Array. Quantitative real-time PCR was performed on the 7900HT Fast Real-Time PCR System (Applied Biosystems). Expression threshold for each miRNA detector was automatically determined. After initial screening, a total of 166 miRNAs could be detected. Among these, we selected 89 miRNAs that are related to cancer pathways or reported in bladder cancer based on literature [57 (link)–62 (link)] for further testing in discovery and validation sets (Supplementary Table 4). MiRNAs with a Ct value < 35 and a missing rate < 25% in both study groups were considered as stably detectable candidates for further analysis.
+ Open protocol
+ Expand
7

Efficient RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA including miRNAs was extracted 2 days post-infection. Briefly, to protect RNA from degradation, macrophages were rinsed with PBS, then scraped with Maxwell® RSC miRNA Tissue Kit homogenization solution/thioglycerol (50/1) (Promega). Followed 10 min of incubation with Maxwell® RSC miRNA Tissue Kit lysis buffer (Promega), cells and bacteria were lysed by bead beating into Matrix B tubes containing silica beads (MP Biomedical) with the Super-Fast Prep-1 instrument (MP Biomedical). Finally, samples were processed into a Maxwell® RSC instrument for RNA extraction. RNA concentration was measured with QIAxpert System (Qiagen) and RNA integrity was evaluated by automated electrophoresis with TapeStation Systems (Agilent). Reverse transcription of total mRNA or miRNAs were performed with 500 ng total RNA using SuperScript™ IV VILO™ Master Mix or a Taqman™ microRNA Reverse Transcription kit (Applied Biosystems), respectively. qPCR amplifications were run with a QuantStudio™ 12K Flex system (Applied Biosystems) and using a customized TaqMan® Array (Table S1 in Supplementary Material) for mRNAs and the TaqMan® Array Human MicroRNA Card Set v3.0 dispatched in two pools: highly characterized miRNAs (pool A) and more recently discovered miRNAs (pool B) (Applied Biosystems) for miRNAs, according to the manufacturer’s instructions.
+ Open protocol
+ Expand
8

Quantitative miRNA Expression Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reverse transcription reaction was performed using the human Megaplex™ primer pools set v3.0 (Life Technologies, Foster City, CA, USA), which contains RT primers for 754 individual miRNAs, according to manufacturer’s instructions. Real-time qRT-PCR was then carried out on an ABI 7900HT real-time PCR machine with the LDA thermal cycler block, using TaqMan® array human microRNA card set v3.0 (Life Technologies) and pre-defined TLDA thermal cycling conditions. Quantitative RT-PCR data were extracted with SDS2.3 and RQ Manager Software (Life Technologies). Thresholds for the determination of Ct values were manually set at 0.2, 0.1, or 0.05 for each miRNA across the 15 samples, depending on the quality of the amplification. Relative fold change was then calculated using the ΔCt method, normalized to RNU48 expression.
+ Open protocol
+ Expand
9

Profiling Peripheral Blood miRNA in Pregnancy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) isolated by Lymphoprep (Axis-Shields, Norway) using the Nucleospin miRNA kit (Merchery-Nagel, Germany) from individuals as presented in Table 1A who took part in the prospective Finnish Multiple Sclerosis and Pregnancy study. For detection of miRNA gene expression TaqMan® Array Human MicroRNA Card Set v3.0 containing 754 miRNA targets for detection was used (Life technologies, USA). Quantitative real-time PCR (qPCR) was run on a ViiA7 system and analysis of fold-changes was performed with DataAssist v3.0 using the 2-ΔΔCT method for relative quantification of miRNA levels. Fold changes of miRNA between 3rd trimester and postpartum samples were analyzed with global normalization and miRNAs with p <0.05 were considered differentially expressed between the two periods.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!